Identification and analysis of multivalent proteolytically resistant peptides from gluten: Implications for Celiac Sprue

Department of Chemical Engineering, Stanford University, Stanford, CA 94305-5025, USA.
Journal of Proteome Research (Impact Factor: 5). 08/2005; 4(5):1732-41. DOI: 10.1021/pr050173t
Source: PubMed

ABSTRACT Dietary gluten proteins from wheat, rye, and barley are the primary triggers for the immuno-pathogenesis of Celiac Sprue, a widespread immune disease of the small intestine. Recent molecular and structural analyses of representative gluten proteins, most notably alpha- and gamma-gliadin proteins from wheat, have improved our understanding of these pathogenic mechanisms. In particular, based on the properties of a 33-mer peptide, generated from alpha-gliadin under physiological conditions, a link between digestive resistance and inflammatory character of gluten has been proposed. Here, we report three lines of investigation in support of this hypothesis. First, biochemical and immunological analysis of deletion mutants of alpha-2 gliadin confirmed that the DQ2 restricted T cell response to the alpha-2 gliadin are directed toward the epitopes clustered within the 33-mer. Second, proteolytic analysis of a representative gamma-gliadin led to the identification of another multivalent 26-mer peptide that was also resistant to further gastric, pancreatic and intestinal brush border degradation, and was a good substrate of human transglutaminase 2 (TG2). Analogous to the 33-mer, the synthetic 26-mer peptide displayed markedly enhanced T cell antigenicity compared to monovalent control peptides. Finally, in silico analysis of the gluten proteome led to the identification of at least 60 putative peptides that share the common characteristics of the 33-mer and the 26-mer peptides. Together, these results highlight the pivotal role of physiologically generated, proteolytically stable, TG2-reactive, multivalent peptides in the immune response to dietary gluten in Celiac Sprue patients. Prolyl endopeptidase treatment was shown to abolish the antigenicity of both the 33-mer and the 26-mer peptides, and was also predicted to have comparable effects on other proline-rich putatively immunotoxic peptides identified from other polypeptides within the gluten proteome.

  • Source
    02/2015; 1:21-27. DOI:10.1016/j.cofs.2014.09.004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Celiac disease (CD) affects approximately 1% of the general population while an estimated additional 6% suffers from a recently characterized, rapidly emerging, similar disease, referred to as non-celiac gluten sensitivity (NCGS). The only effective treatment of CD and NCGS requires removal of gluten sources from the diet. Since required adherence to a gluten-free diet (GFD) is difficult to accomplish, efforts to develop alternative treatments have been intensifying in recent years. In this study, the non-human primate model of CD/NCGS, e.g., gluten-sensitive rhesus macaque, was utilized with the objective to evaluate the treatment potential of reduced gluten cereals using a reduced gluten (RG; 1% of normal gluten) barley mutant as a model. Conventional and RG barleys were used for the formulation of experimental chows and fed to gluten-sensitive (GS) and control macaques to determine if RG barley causes a remission of dietary gluten-induced clinical and immune responses in GS macaques. The impacts of the RG barley diet were compared with the impacts of the conventional barley-containing chow and the GFD. Although remission of the anti-gliadin antibody (AGA) serum responses and an improvement of clinical diarrhea were noted after switching the conventional to the RG barley diet, production of OPEN ACCESS Nutrients 2015, 7 1658 inflammatory cytokines, e.g., interferon-gamma (IFN-γ), tumor necrosis factor (TNF) and interleukin-8 (IL-8) by peripheral CD4+ T helper lymphocytes, persisted during the RG chow treatment and were partially abolished only upon re-administration of the GFD. It was concluded that the RG barley diet might be used for the partial improvement of gluten-induced disease but its therapeutic value still requires upgrading—by co-administration of additional treatments.
    Nutrients 03/2015; 7(3):1657-1671. DOI:10.3390/nu7031657 · 3.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A series of proteomic procedures has been applied to analyze beer and wort proteomes including two-dimensional gel electrophoresis combined with mass spectrometry (MS), pre-fractionation followed by gel electrophoresis and MS, and gel-free based shotgun liquid chromatography-MS/MS. These approaches have detected a number of protein species in beer and wort, from barley and yeast, and occasionally from rice and maize. Of these beer proteins, barley dimeric alpha-amylase inhibitor-1 (BDAI-1), barley trypsin inhibitor-CMe precursor (BTI-CMe) and yeast thioredoxin have been identified as factors responsible for beer quality traits of foam and haze. In addition, a number of hordein derived polypeptides involved to celiac disease have also been identified. Among these proteins and peptides, the modifications such as glycation and partial digestion in several proteins such as lipid transfer protein (LW) and protein Z have been characterized. These findings may provide novel tools to improve quality control during beer processing and they may enhance selection in malting barley breeding.
    Food Research International 11/2013; 54(1):1013-1020. DOI:10.1016/j.foodres.2012.11.028 · 3.05 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014